/
RSS Feed
Nearly one year after DNA sequencing machine maker Illumina announced plans to acquire smaller rival Pacific Biosciences, antitrust regulators in the UK say the merger could stifle competition in the region and reduce industry innovation. The Competition and Markets Authority has been studying the proposed $1.2 billion tie-up since April. The regulator?s in-depth review, which [?]
